168 related articles for article (PubMed ID: 36535493)
1. New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties.
Xia Q; Wang W; Liu Z; Xiao J; Qiao C; Zhao Y; Li B; Liu Y; Peng Y; Yang X; Shi J; Gao X; Wang D
Eur J Pharmacol; 2023 Jan; 939():175433. PubMed ID: 36535493
[TBL] [Abstract][Full Text] [Related]
2. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.
Kuang H; Duan Y; Li D; Xu Y; Ai W; Li W; Wang Y; Liu S; Li M; Liu X; Shao M
PLoS One; 2020; 15(8):e0235404. PubMed ID: 32785222
[TBL] [Abstract][Full Text] [Related]
3. Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression.
He S; Li H; Zhang Q; Zhao W; Li W; Dai C; Li B; Cheng J; Wu S; Zhou Z; Yang J; Li S
Phytomedicine; 2024 Jun; 128():155456. PubMed ID: 38537446
[TBL] [Abstract][Full Text] [Related]
4. Effect and mechanism of berberine against polycystic ovary syndrome.
Zhang SW; Zhou J; Gober HJ; Leung WT; Wang L
Biomed Pharmacother; 2021 Jun; 138():111468. PubMed ID: 33740526
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome management: a review of the possible amazing role of berberine.
Rondanelli M; Infantino V; Riva A; Petrangolini G; Faliva MA; Peroni G; Naso M; Nichetti M; Spadaccini D; Gasparri C; Perna S
Arch Gynecol Obstet; 2020 Jan; 301(1):53-60. PubMed ID: 32060683
[TBL] [Abstract][Full Text] [Related]
6. Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome.
Wang Z; Nie K; Su H; Tang Y; Wang H; Xu X; Dong H
Phytomedicine; 2021 Oct; 91():153654. PubMed ID: 34333328
[TBL] [Abstract][Full Text] [Related]
7. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
[TBL] [Abstract][Full Text] [Related]
8. Inositol for subfertile women with polycystic ovary syndrome.
Showell MG; Mackenzie-Proctor R; Jordan V; Hodgson R; Farquhar C
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012378. PubMed ID: 30570133
[TBL] [Abstract][Full Text] [Related]
9. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.
Sharpe A; Morley LC; Tang T; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013505. PubMed ID: 31845767
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.
Bordewijk EM; Ng KYB; Rakic L; Mol BWJ; Brown J; Crawford TJ; van Wely M
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001122. PubMed ID: 32048270
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome.
Wu XK; Wang YY; Liu JP; Liang RN; Xue HY; Ma HX; Shao XG; Ng EH;
Fertil Steril; 2016 Sep; 106(3):757-765.e1. PubMed ID: 27336209
[TBL] [Abstract][Full Text] [Related]
12. Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study.
Rondanelli M; Riva A; Petrangolini G; Allegrini P; Giacosa A; Fazia T; Bernardinelli L; Gasparri C; Peroni G; Perna S
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684666
[TBL] [Abstract][Full Text] [Related]
13. The role of berberine in polycystic ovary syndrome - a summary of knowledge.
Jurgiel J; Graniak A; Opyd P; Zawodny T; Lis M
Ginekol Pol; 2024; 95(4):276-284. PubMed ID: 38108460
[TBL] [Abstract][Full Text] [Related]
14. [Application of metabolomics in treating polycystic ovary syndrome with berberine based on ultra high performance liquid chromatography-mass spectrometry].
Li Y; Zhang C; Zhang H; Zhao X; Hou L; Xu G
Se Pu; 2014 May; 32(5):464-71. PubMed ID: 25185305
[TBL] [Abstract][Full Text] [Related]
15. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.
Zhang N; Liu X; Zhuang L; Liu X; Zhao H; Shan Y; Liu Z; Li F; Wang Y; Fang J
Regul Toxicol Pharmacol; 2020 Feb; 110():104544. PubMed ID: 31778716
[TBL] [Abstract][Full Text] [Related]
16. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies.
Merviel P; James P; Bouée S; Le Guillou M; Rince C; Nachtergaele C; Kerlan V
Reprod Health; 2021 Jan; 18(1):13. PubMed ID: 33468143
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
18. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.
Seow KM; Chang YW; Chen KH; Juan CC; Huang CY; Lin LT; Tsui KH; Chen YJ; Lee WL; Wang PH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142702
[TBL] [Abstract][Full Text] [Related]
20. Systemic and ovarian inflammation in women with polycystic ovary syndrome.
Zhai Y; Pang Y
J Reprod Immunol; 2022 Jun; 151():103628. PubMed ID: 35472833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
